An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia
Article
Park, CW, Park, JS, Shim, SS et al. (2005). An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia
. American Journal of Obstetrics and Gynecology, 193(3), 984-989. 10.1016/j.ajog.2005.06.033
Park, CW, Park, JS, Shim, SS et al. (2005). An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia
. American Journal of Obstetrics and Gynecology, 193(3), 984-989. 10.1016/j.ajog.2005.06.033